# Phase 3 implementation audit — 2026-07-20

Status: **repository implementation PASS; formal phase gate OPEN**.

## Delivered

- Versioned, checksummed population frames, cells, methodology, provider, and simulation configuration registries.
- Exact deterministic weighted sampling with audience filters, minimum-cell rules, and empty/sparse failure behavior.
- Structured cohort provider contract plus deterministic and transport-injected external adapters.
- Schema, identity, coverage, token, cost, deadline, and untrusted-receipt enforcement.
- Aggregation with sparse-cell suppression, explicit uncertainty/stability metadata, and reproducibility receipts.
- Evaluation harness with overall/slice metrics and no automatic validation promotion.
- Authenticated registry, audience, configuration, and zero-cost preview APIs.
- Browser workflow: audience builder -> frozen configuration -> synthetic report with method/limitation disclosures.

## Evidence

| Gate | Result |
| --- | --- |
| Methodology unit tests | 12 passed |
| Full non-integration suite | 248 passed, 2 expected Windows skips |
| Web tests | 58 passed |
| Contract tests | 2 passed |
| Phase 3/4 real API/DB/worker integration | 1 passed |
| Full integration regression | 24 passed |
| Clean migration replay | passed |
| Database lint | `results: []` |
| pgTAP | 68/68 passed |
| Production build | passed |
| Browser verification | auth, audience, config, preview/report; 0 console errors |
| Repository `pnpm check` | passed |

## Audit judgment

The Phase 3 code scope in `brain/Product/PRD.md` is implemented locally. Outputs remain heuristic synthetic diagnostics; the implementation makes no participant, population, representativeness, or outcome claim.

Formal promotion remains open. Canonical Phase 2 prerequisites still require human keyboard/screen-reader evidence and enforceable required-check governance. No live provider call, human benchmark, scientific validation, hosted application deployment, or production authorization was performed.
